- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$202.73
7D
6.5%
1Y
35.5%
BioNTech
Market Cap: US$21.6b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$89.31
7D
-0.9%
1Y
-7.2%
Illumina
Market Cap: US$18.8b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$126.59
7D
9.5%
1Y
49.3%
Regencell Bioscience Holdings
Market Cap: US$13.0b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$27.01
7D
12.5%
1Y
2,180.8%
Elanco Animal Health
Market Cap: US$12.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.12
7D
10.8%
1Y
137.4%
Sam Chun Dang Pharm
Market Cap: ₩18.5t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩907,000.00
7D
17.5%
1Y
380.4%